Literature DB >> 27704304

Adherence to ACIP Recommendation for Human Papillomavirus Vaccine Among US Adolescent Girls.

Mahbubur Rahman1,2, Jacqueline M Hirth3, Abbey B Berenson3.   

Abstract

The objective of this study was to examine correlates of human papillomavirus (HPV) vaccine use according to Advisory Committee on Immunization Practices (ACIP)'s recommendations among US adolescent girls. We used National Immunization Survey of Teens 2013 data. Based on provider-verified (n = 9403) information, 57.3, 39.1 and 19.0 % of adolescent girls, initiated, completed and completed the HPV vaccine according to ACIP's recommendation (by age 12), respectively. Hispanic race/ethnicity, a physician recommendation for HPV vaccine and ≥1 influenza vaccine in the past 3 years were all associated with a higher likelihood of compliance with ACIP's recommendation. Girls from a larger family and those whose immunization provider was a STD/school/teen clinic were less likely to receive the vaccine at the recommended age compared to a girl raised in a smaller sized family and received immunization from a hospital facility, respectively. Only one-fifth of 13-17 yo girls receive the HPV vaccine by age 12 as recommended by ACIP. Physician visits and influenza vaccination settings are opportunities to improve vaccine series completion at the recommended age.

Entities:  

Keywords:  Advisory Committee on Immunization Practices; Human papillomavirus; Vaccine completion; Vaccine initiation

Mesh:

Substances:

Year:  2017        PMID: 27704304     DOI: 10.1007/s10900-016-0267-6

Source DB:  PubMed          Journal:  J Community Health        ISSN: 0094-5145


  16 in total

1.  Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses.

Authors:  Jessica A Kahn; Lili Ding; Bin Huang; Gregory D Zimet; Susan L Rosenthal; A Lindsay Frazier
Journal:  Pediatrics       Date:  2009-06       Impact factor: 7.124

2.  Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure.

Authors:  Matthew F Daley; Lori A Crane; Lauri E Markowitz; Sandra R Black; Brenda L Beaty; Jennifer Barrow; Christine Babbel; Sami L Gottlieb; Nicole Liddon; Shannon Stokley; L Miriam Dickinson; Allison Kempe
Journal:  Pediatrics       Date:  2010-08-02       Impact factor: 7.124

3.  Age at HPV vaccine initiation and completion among US adolescent girls: trend from 2008 to 2012.

Authors:  Mahbubur Rahman; Christine J McGrath; Jacqueline M Hirth; Abbey B Berenson
Journal:  Vaccine       Date:  2014-12-18       Impact factor: 3.641

4.  A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

Authors:  Elmar A Joura; Anna R Giuliano; Ole-Erik Iversen; Celine Bouchard; Constance Mao; Jesper Mehlsen; Edson D Moreira; Yuen Ngan; Lone Kjeld Petersen; Eduardo Lazcano-Ponce; Punnee Pitisuttithum; Jaime Alberto Restrepo; Gavin Stuart; Linn Woelber; Yuh Cheng Yang; Jack Cuzick; Suzanne M Garland; Warner Huh; Susanne K Kjaer; Oliver M Bautista; Ivan S F Chan; Joshua Chen; Richard Gesser; Erin Moeller; Michael Ritter; Scott Vuocolo; Alain Luxembourg
Journal:  N Engl J Med       Date:  2015-02-19       Impact factor: 91.245

5.  Prevalence of HPV infection among females in the United States.

Authors:  Eileen F Dunne; Elizabeth R Unger; Maya Sternberg; Geraldine McQuillan; David C Swan; Sonya S Patel; Lauri E Markowitz
Journal:  JAMA       Date:  2007-02-28       Impact factor: 56.272

6.  Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women.

Authors:  Stan L Block; Terry Nolan; Carlos Sattler; Eliav Barr; Katherine E D Giacoletti; Colin D Marchant; Xavier Castellsagué; Steven A Rusche; Suzanne Lukac; Janine T Bryan; Paul F Cavanaugh; Keith S Reisinger
Journal:  Pediatrics       Date:  2006-11       Impact factor: 7.124

7.  Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system.

Authors:  Amanda Dempsey; Lisa Cohn; Vanessa Dalton; Mack Ruffin
Journal:  Vaccine       Date:  2009-11-17       Impact factor: 3.641

Review 8.  Female human papillomavirus (HPV) vaccination: global uptake and the impact of attitudes.

Authors:  Tom Glass Hopkins; Nick Wood
Journal:  Vaccine       Date:  2013-01-30       Impact factor: 3.641

Review 9.  Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.

Authors:  F Xavier Bosch; Ann N Burchell; Mark Schiffman; Anna R Giuliano; Silvia de Sanjose; Laia Bruni; Guillermo Tortolero-Luna; Susanne Kruger Kjaer; Nubia Muñoz
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

10.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years--United States, 2014.

Authors:  Sarah Reagan-Steiner; David Yankey; Jenny Jeyarajah; Laurie D Elam-Evans; James A Singleton; C Robinette Curtis; Jessica MacNeil; Lauri E Markowitz; Shannon Stokley
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-31       Impact factor: 17.586

View more
  5 in total

Review 1.  Racial Disparity in Gastrointestinal Cancer Risk.

Authors:  Hassan Ashktorab; Sonia S Kupfer; Hassan Brim; John M Carethers
Journal:  Gastroenterology       Date:  2017-08-12       Impact factor: 22.682

2.  Human Papilloma Virus Vaccination Among Adolescents in a Community Clinic Before and After Intervention.

Authors:  M Varman; C Sharlin; C Fernandez; J Vasudevan; C Wichman
Journal:  J Community Health       Date:  2018-06

3.  Human Papillomavirus Vaccine-Related Risk Perceptions Do Not Predict Sexual Initiation Among Young Women Over 30 Months Following Vaccination.

Authors:  Tanya L Kowalczyk Mullins; Susan L Rosenthal; Gregory D Zimet; Lili Ding; Charlene Morrow; Bin Huang; Jessica A Kahn
Journal:  J Adolesc Health       Date:  2017-12-02       Impact factor: 5.012

4.  A systematic review of human papillomavirus vaccination among US adolescents.

Authors:  Lisa N Mansfield; Ashlee Vance; Jacqueline A Nikpour; Rosa M Gonzalez-Guarda
Journal:  Res Nurs Health       Date:  2021-04-16       Impact factor: 2.238

Review 5.  [Human papillomavirus vaccine receptivity: a systematic reviewReceptividad con respecto a la vacuna contra el virus del papiloma humano: revisión sistemática].

Authors:  Lídia Ester Lopes da Silva; Maria Liz Cunha de Oliveira; Dayani Galato
Journal:  Rev Panam Salud Publica       Date:  2019-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.